FIELD: medicine.
SUBSTANCE: what is presented is using Zincatran (a complex of tris-(2-hydroxyethyl)amine and zinc bis-(2-methylphenoxy-acetate)) as a hypolipidemic and antiatherosclerotic agent.
EFFECT: new antiatherosclerotic medicinal agent possesses higher efficacy as compared to trecresan in a dose, which is five times less than a dose of trecresan; if administered in a continuous manner, it enables to avoid side effects.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXYACETATE) (CINKATRAN) AS AGENT SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) MONONUCLEAR PHOSPHOLIPASE A2 | 2014 |
|
RU2546537C1 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND BIS-(2-METHYLPHENOXY-ACETATE) ZINC (ZINCATRAN) FOR REDUCING TOTAL ACTIVITY OF ACIDIC PHOSPHOLIPASE A1 | 2014 |
|
RU2545888C1 |
| APPLICATION OF PROTATRAN 4-CHLORO-2-METHYLPHENOXYACETATE FOR EXHAUSTING OF MONONUCLEAR CELLS BASIC (ALKALINE) PHOSPHOLIPASE a2 TOTAL ACTIVITY | 2016 |
|
RU2619860C1 |
| SUBSTANCE REDUCING CHOLESTEROL ESTERASE ACTIVITY | 2014 |
|
RU2540518C1 |
| USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY | 2014 |
|
RU2563831C1 |
| USE OF AN AQUEOUS SOLUTION OF PROTRAN 4-CHLORO-2-METHYLPHENOXYACETATE (CHLORINE CREZACIN) TO STIMULATE STATIC AND DYNAMIC OPERABILITY | 2019 |
|
RU2734899C1 |
| USING PROTATRAN 4-CHLORO-2-METHYLPHENOXYACETATE (CHLORINE CREZACIN) IN 0_9 % SODIUM CHLORIDE SOLUTION TO STIMULATE STATIC AND DYNAMIC OPERABILITY | 2019 |
|
RU2734728C1 |
| WORKING ABILITY IMPROVEMENT | 2014 |
|
RU2540476C1 |
| METHOD FOR CORRECTING ATHEROGENESIS EXPERIMENTALLY USING 1-HYDROXYGERMATRANE | 2020 |
|
RU2741229C1 |
| USING ZINC COMPLEX-TRIS-(2-HYDROXYETHYL)AMINE WITH BIS-(2-METHYLPHENOXYACETATE) (ZINCATRANE) FOR STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2014 |
|
RU2540469C1 |
